Complement Factor C7 Contributes to Lung Immunopathology Caused by Mycobacterium tuberculosis
暂无分享,去创建一个
[1] Devin R. Lindsey,et al. A defect in the synthesis of Interferon-γ by the T cells of Complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis. , 2011, Tuberculosis.
[2] K. J. Welsh,et al. Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen. , 2011, Tuberculosis.
[3] R. Hunter,et al. Lactoferrin modulation of mycobacterial cord factor trehalose 6-6'-dimycolate induced granulomatous response. , 2010, Translational research : the journal of laboratory and clinical medicine.
[4] W. Bishai,et al. Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view , 2010, Cellular microbiology.
[5] A. van der Ende,et al. Complement factor 7 gene mutations in relation to meningococcal infection and clinical recurrence of meningococcal disease. , 2010, Molecular immunology.
[6] G. Kaplan,et al. Advances in immunotherapy for tuberculosis treatment. , 2009, Clinics in chest medicine.
[7] A. Krarup,et al. Multiple routes of complement activation by Mycobacterium bovis BCG. , 2008, Molecular immunology.
[8] R. Hunter,et al. A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response. , 2008, Microbiology.
[9] M. Braun,et al. Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a. , 2008, Molecular immunology.
[10] S. Kaufmann,et al. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis , 2007, Proceedings of the National Academy of Sciences.
[11] S. Jolles,et al. Current strategies in TB immunotherapy. , 2007, Current molecular medicine.
[12] E. Reis,et al. Complement components, regulators and receptors are produced by human monocyte-derived dendritic cells. , 2007, Immunobiology.
[13] J. Atkinson,et al. T-cell regulation: with complements from innate immunity , 2007, Nature Reviews Immunology.
[14] B. Morgan,et al. Cutting Edge: Murine CD59a Modulates Antiviral CD4+ T Cell Activity in a Complement-Independent Manner1 , 2005, The Journal of Immunology.
[15] R. Hunter,et al. Requisite Role for Complement C5 and the C5a Receptor in Granulomatous Response to Mycobacterial Glycolipid Trehalose 6,6′‐Dimycolate , 2005, Scandinavian journal of immunology.
[16] J. Ellner,et al. Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. , 2005, The Journal of infectious diseases.
[17] Shin-Il Kim,et al. Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship. , 2004, Clinical immunology.
[18] J. Köhl,et al. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. , 2004, Molecular immunology.
[19] John L. Johnson,et al. A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis , 2004, AIDS.
[20] M. Gadjeva,et al. Myeloid C3 Determines Induction of Humoral Responses to Peripheral Herpes Simplex Virus Infection 1 , 2003, The Journal of Immunology.
[21] John D Lambris,et al. Complement Component 3 Is Required for Optimal Expansion of CD8 T Cells During a Systemic Viral Infection1 , 2003, The Journal of Immunology.
[22] D. Corry,et al. Absence of the Complement Anaphylatoxin C3a Receptor Suppresses Th2 Effector Functions in a Murine Model of Pulmonary Allergy1 , 2002, The Journal of Immunology.
[23] R. Hunter,et al. Influence of trehalose 6,6'-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. , 2002, Microbiology.
[24] M. Bachmann,et al. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection , 2002, Nature Medicine.
[25] J. Bower,et al. Role of Complement in Mycobacterium avium Pathogenesis: In Vivo and In Vitro Analyses of the Host Response to Infection in the Absence of Complement Component C3 , 2001, Infection and Immunity.
[26] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[27] Rick A. Wetsel,et al. Cutting Edge: The Absence of C3 Demonstrates a Role for Complement in Th2 Effector Functions in a Murine Model of Pulmonary Allergy1 , 2001, The Journal of Immunology.
[28] C. Jagannath,et al. A Role for Complement C5 in Organism Containment and Granulomatous Response during Murine Tuberculosis , 2001, Scandinavian journal of immunology.
[29] C. Sohaskey,et al. Nonreplicating persistence of mycobacterium tuberculosis. , 2001, Annual review of microbiology.
[30] R. Hunter,et al. Hypersusceptibility of A/J Mice to Tuberculosis is in Part Due to a Deficiency of the Fifth Complement Component (C5) , 2000, Scandinavian journal of immunology.
[31] A. Rao,et al. Molecular aspects of T-cell differentiation. , 2000, British medical bulletin.
[32] E. Peerschke,et al. Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. , 1994, Journal of immunology.
[33] E. Shevach,et al. CD59 functions as a signal-transducing molecule for human T cell activation. , 1991, Journal of immunology.
[34] M. Horwitz,et al. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.
[35] G. Hetland,et al. Human Alveolar Macrophages Synthesize the Functional Alternative Pathway of Complement and Active C5 and C9 in Vitro , 1986, Scandinavian journal of immunology.
[36] Thomas D. Schmittgen,et al. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .